Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Price to Book Value: 2.647 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.647 |
| November 21, 2024 | 2.625 |
| November 20, 2024 | 2.540 |
| November 19, 2024 | 2.516 |
| November 18, 2024 | 2.535 |
| November 15, 2024 | 2.538 |
| November 14, 2024 | 2.662 |
| November 13, 2024 | 2.792 |
| November 12, 2024 | 2.920 |
| November 11, 2024 | 2.984 |
| November 08, 2024 | 2.912 |
| November 07, 2024 | 2.843 |
| November 06, 2024 | 2.896 |
| November 05, 2024 | 2.551 |
| November 04, 2024 | 2.467 |
| November 01, 2024 | 2.447 |
| October 31, 2024 | 2.414 |
| October 30, 2024 | 2.452 |
| October 29, 2024 | 2.488 |
| October 28, 2024 | 2.522 |
| October 25, 2024 | 2.462 |
| October 24, 2024 | 2.470 |
| October 23, 2024 | 2.523 |
| October 22, 2024 | 2.514 |
| October 21, 2024 | 2.637 |
| Date | Value |
|---|---|
| October 18, 2024 | 2.674 |
| October 17, 2024 | 2.674 |
| October 16, 2024 | 2.638 |
| October 15, 2024 | 2.621 |
| October 14, 2024 | 2.611 |
| October 11, 2024 | 2.609 |
| October 10, 2024 | 2.588 |
| October 09, 2024 | 2.538 |
| October 08, 2024 | 2.526 |
| October 07, 2024 | 2.558 |
| October 04, 2024 | 2.579 |
| October 03, 2024 | 2.563 |
| October 02, 2024 | 2.608 |
| October 01, 2024 | 2.624 |
| September 30, 2024 | 2.663 |
| September 27, 2024 | 2.750 |
| September 26, 2024 | 2.750 |
| September 25, 2024 | 2.675 |
| September 24, 2024 | 2.782 |
| September 23, 2024 | 2.826 |
| September 20, 2024 | 2.854 |
| September 19, 2024 | 2.907 |
| September 18, 2024 | 2.858 |
| September 17, 2024 | 2.860 |
| September 16, 2024 | 2.826 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.414
Minimum
Oct 31 2024
9.962
Maximum
Sep 24 2021
4.923
Average
4.380
Median
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.406 |
| CVS Health Corp | 0.9741 |
| Arbutus Biopharma Corp | 6.222 |
| FibroBiologics Inc | 32.92 |
| Biomarin Pharmaceutical Inc | 2.262 |
Price to Book Value Related Metrics
| PE Ratio | 24.44 |
| PS Ratio | 2.490 |
| Price to Free Cash Flow | 18.04 |
| Price | 195.77 |
| Earnings Yield | 4.09% |
| Market Cap | 10.01B |
| Operating PE Ratio | 19.15 |
| Normalized PE Ratio | 24.44 |